198 related articles for article (PubMed ID: 8083355)
1. Insulin receptor substrate-1 variants in non-insulin-dependent diabetes.
Laakso M; Malkki M; Kekäläinen P; Kuusisto J; Deeb SS
J Clin Invest; 1994 Sep; 94(3):1141-6. PubMed ID: 8083355
[TBL] [Abstract][Full Text] [Related]
2. Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene in Japanese patients with NIDDM: identification of five novel polymorphisms.
Ura S; Araki E; Kishikawa H; Shirotani T; Todaka M; Isami S; Shimoda S; Yoshimura R; Matsuda K; Motoyoshi S; Miyamura N; Kahn CR; Shichiri M
Diabetologia; 1996 May; 39(5):600-8. PubMed ID: 8739921
[TBL] [Abstract][Full Text] [Related]
3. No association between the Gly971Arg variant of the insulin receptor substrate 1 gene and NIDDM in the Taiwanese population.
Chuang LM; Lai CS; Yeh JI; Wu HP; Tai TY; Lin BJ
Diabetes Care; 1996 May; 19(5):446-9. PubMed ID: 8732707
[TBL] [Abstract][Full Text] [Related]
4. Amino acid substitutions in hexokinase II among patients with NIDDM.
Laakso M; Malkki M; Deeb SS
Diabetes; 1995 Mar; 44(3):330-4. PubMed ID: 7883120
[TBL] [Abstract][Full Text] [Related]
5. Molecular scanning for mutations in the insulin receptor substrate-1 (IRS-1) gene in Mexican Americans with Type 2 diabetes mellitus.
Celi FS; Negri C; Tanner K; Raben N; De Pablo F; Rovira A; Pallardo LF; Martin-Vaquero P; Stern MP; Mitchell BD; Shuldiner AR
Diabetes Metab Res Rev; 2000; 16(5):370-7. PubMed ID: 11025561
[TBL] [Abstract][Full Text] [Related]
6. Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus.
Imai Y; Fusco A; Suzuki Y; Lesniak MA; D'Alfonso R; Sesti G; Bertoli A; Lauro R; Accili D; Taylor SI
J Clin Endocrinol Metab; 1994 Dec; 79(6):1655-8. PubMed ID: 7989470
[TBL] [Abstract][Full Text] [Related]
7. Codon 972 polymorphism in the insulin receptor substrate-1 gene, obesity, and risk of noninsulin-dependent diabetes mellitus.
Sigal RJ; Doria A; Warram JH; Krolewski AS
J Clin Endocrinol Metab; 1996 Apr; 81(4):1657-9. PubMed ID: 8636384
[TBL] [Abstract][Full Text] [Related]
8. Identification of four amino acid substitutions in hexokinase II and studies of relationships to NIDDM, glucose effectiveness, and insulin sensitivity.
Echwald SM; Bjørbaek C; Hansen T; Clausen JO; Vestergaard H; Zierath JR; Printz RL; Granner DK; Pedersen O
Diabetes; 1995 Mar; 44(3):347-53. PubMed ID: 7883123
[TBL] [Abstract][Full Text] [Related]
9. Common amino acid substitutions in insulin receptor substrate-4 are not associated with Type II diabetes mellitus or insulin resistance.
Almind K; Frederiksen SK; Ahlgren MG; Urhammer S; Hansen T; Clausen JO; Pedersen O
Diabetologia; 1998 Aug; 41(8):969-74. PubMed ID: 9726601
[TBL] [Abstract][Full Text] [Related]
10. Variant sequences of the Hexokinase II gene in familial NIDDM.
Taylor RW; Printz RL; Armstrong M; Granner DK; Alberti KG; Turnbull DM; Walker M
Diabetologia; 1996 Mar; 39(3):322-8. PubMed ID: 8721778
[TBL] [Abstract][Full Text] [Related]
11. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus.
Almind K; Bjørbaek C; Vestergaard H; Hansen T; Echwald S; Pedersen O
Lancet; 1993 Oct; 342(8875):828-32. PubMed ID: 8104271
[TBL] [Abstract][Full Text] [Related]
12. New amino acid substitutions in the IRS-2 gene in Finnish and Chinese subjects with late-onset type 2 diabetes.
Wang H; Rissanen J; Miettinen R; Kärkkäinen P; Kekäläinen P; Kuusisto J; Mykkänen L; Karhapää P; Laakso M
Diabetes; 2001 Aug; 50(8):1949-51. PubMed ID: 11473060
[TBL] [Abstract][Full Text] [Related]
13. Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease.
Hitman GA; Hawrami K; McCarthy MI; Viswanathan M; Snehalatha C; Ramachandran A; Tuomilehto J; Tuomilehto-Wolf E; Nissinen A; Pedersen O
Diabetologia; 1995 Apr; 38(4):481-6. PubMed ID: 7796990
[TBL] [Abstract][Full Text] [Related]
14. Amino acid polymorphisms of the insulin receptor substrate-1 in Japanese noninsulin-dependent diabetes mellitus.
Mori H; Hashiramoto M; Kishimoto M; Kasuga M
J Clin Endocrinol Metab; 1995 Sep; 80(9):2822-6. PubMed ID: 7673430
[TBL] [Abstract][Full Text] [Related]
15. Human insulin receptor substrate-1: variant sequences in familial non-insulin-dependent diabetes mellitus.
Armstrong M; Haldane F; Taylor RW; Humphriss D; Berrish T; Stewart MW; Turnbull DM; Alberti KG; Walker M
Diabet Med; 1996 Feb; 13(2):133-8. PubMed ID: 8641117
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance.
Laakso M; Malkki M; Kekäläinen P; Kuusisto J; Deeb SS
Diabetologia; 1995 May; 38(5):617-22. PubMed ID: 7489847
[TBL] [Abstract][Full Text] [Related]
17. Codon 972 polymorphism of the insulin receptor substrate-1 gene in impaired glucose tolerance and late-onset NIDDM.
Yamada K; Yuan X; Ishiyama S; Shoji S; Kohno S; Koyama K; Koyanagi A; Koyama W; Nonaka K
Diabetes Care; 1998 May; 21(5):753-6. PubMed ID: 9589236
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity.
Stefan N; Kovacs P; Stumvoll M; Hanson RL; Lehn-Stefan A; Permana PA; Baier LJ; Tataranni PA; Silver K; Bogardus C
Diabetes; 2003 Jun; 52(6):1544-50. PubMed ID: 12765968
[TBL] [Abstract][Full Text] [Related]
19. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
Vestergaard H; Bjørbaek C; Hansen T; Larsen FS; Granner DK; Pedersen O
J Clin Invest; 1995 Dec; 96(6):2639-45. PubMed ID: 8675629
[TBL] [Abstract][Full Text] [Related]
20. UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study.
Zhang Y; Wat N; Stratton IM; Warren-Perry MG; Orho M; Groop L; Turner RC
Diabetologia; 1996 Dec; 39(12):1505-11. PubMed ID: 8960833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
